Investor Consortium’s Proposed Take-Private of Cellular Biomedicine

Michael Patrini

Kirkland & Ellis is advising an investor consortium led by Mr. Bizuo (Tony) Liu, the Chief Executive Officer of Cellular Biomedicine Group Inc. (NASDAQ: CBMG), certain…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Michael Patrini

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here